✦ LIBER ✦

The pharmacogenetics of antidepressant treatments for depressive disorders

✍ Scribed by Min-Soo Lee

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 101 KB
Volume: 65
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.20020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic study of serotonin 6 rec

Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

✍ Taro Kishi; Yasuhisa Fukuo; Reiji Yoshimura; Tomo Okochi; Tsuyoshi Kitajima; Hir 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract ## Objective Several investigations have suggested that alterations in serotonin 6 (5‐HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5‐HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI)

Antidepressant treatment for depression:

Antidepressant treatment for depression: total charges and therapy duration

✍ Deborah G. Dobrez; Catherine A. Melfi; Thomas W. Croghan; Professor Thomas J. Kn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

## Abstract ## Background: The economic costs of depression are significant, both the direct medical costs of care and the indirect costs of lost productivity. Empirical studies of antidepressant cost‐effectiveness suggest that the use of selective serotonin reuptake inhibitors (SSRIs) may be no m

A comparison of two treatments for depre

A comparison of two treatments for depression: The antidepressive program vs. traditional therapy

✍ Allen P. Wadsworth Jr.; Harry R. Barker Jr. 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

Neuroendocrine and anthropometric measur

Neuroendocrine and anthropometric measures in major depression: the effect of antidepressant treatment

✍ Arun Ravindran; Robert Bialik; Pavel Hrdina; Zul Merali; Hymie Anisman; Yvon Lap 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

It has been suggested that weight change might be associated with certain neuroendocrine abnormalities often observed in patients suering from a depressive illness. This preliminary study examined whether objective measures of weight change were associated with dexamethasone suppression test (DST) r

The combination of duloxetine and buprop

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission

Proteomic analysis of protein changes de

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

✍ Xavier Khawaja; Jun Xu; Jin-Jun Liang; James E. Barrett 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

## Abstract It is recognized that monoamine reuptake inhibitors (MARIs) exert beneficial effects in the treatment of major depression and general anxiety disorder. The aim of this study was to identify proteins regulated by this class of antidepressant using a proteome differential profiling approa